Oncology Nursing Drug Handbook 2004
, by Wilkes, Gail M.
- ISBN: 9780763748517 | 076374851X
- Cover: Paperback
- Copyright: 11/1/2003
The book is a comprehensive nursing resource for assessment, intervention, and patient education in the administration of oncology drugs.
Gail M. Wilkes, RN, MS, AOCN Oncology Nurse Practitioner and Clinical Instructor Boston Medical Center Boston, Massachusetts Margaret Barton-Burke, RN, PhD, AOCN Oncology Nursing Consultant West Roxbury, Massachusetts
| Key to Abbreviations | p. xiii |
| Preface | p. xvii |
| Contributors | p. xix |
| Cancer Treatment | p. 1 |
| Introduction to Chemotherapy Drugs | p. 2 |
| Acridinyl anisidide | p. 38 |
| Adrenocorticoids | p. 41 |
| Altretamine | p. 45 |
| 9-Aminocamptothecin | p. 48 |
| Aminoglutethimide | p. 49 |
| Anastrozole | p. 52 |
| Androgens: testosterone propionate, obfluoxymesterone, obstestolactone | p. 54 |
| Arsenic trioxide | p. 56 |
| Asparaginase | p. 63 |
| 5-Azacytidine | p. 66 |
| Bicalutamide | p. 69 |
| Bleomycin sulfate | p. 70 |
| Busulfan | p. 73 |
| Busulfan for injection | p. 75 |
| Capecitabine | p. 82 |
| Carboplatin | p. 85 |
| Carmustine | p. 88 |
| Chlorambucil | p. 92 |
| Cisplatin | p. 94 |
| Cladribine | p. 100 |
| Cyclophosphamide | p. 103 |
| Cytarbine, cytosine arabinoside | p. 108 |
| Cytarabine liposome injection | p. 112 |
| Dacarbazine | p. 113 |
| Dactinomycin | p. 117 |
| Daunorubicin citrate liposome injection | p. 120 |
| Daunorubicin hydrochloride | p. 123 |
| Decitabine | p. 127 |
| Docetaxel | p. 128 |
| Doxorubicin hydrochloride | p. 137 |
| Doxorubicin hydrochloride liposome injection | p. 140 |
| Eniluracil | p. 146 |
| Epirubicin HCl | p. 148 |
| Estramustine | p. 153 |
| Estrogens: diethylstilbestrone, ethinyl estradiol, conjugated estrogen, chlorotrianisene | p. 156 |
| Etoposide | p. 158 |
| Exemestane | p. 162 |
| Floxuridine | p. 165 |
| Fludarabine phosphate | p. 168 |
| 5-Fluorouracil | p. 170 |
| Flutamide | p. 173 |
| Fulvestrant injection | p. 174 |
| Gemcitabine | p. 177 |
| Goserelin acetate | p. 181 |
| Hydroxyurea | p. 184 |
| Idarubicin | p. 187 |
| Idoxifene | p. 190 |
| Ifosfamide | p. 191 |
| Irinotecan | p. 195 |
| Ketoconazole | p. 200 |
| Letrozole | p. 204 |
| Leuprolide acetate | p. 205 |
| Lomustine | p. 208 |
| Mechlorethamine hydrochloride | p. 210 |
| Melphalan hydrochloride | p. 214 |
| Menogaril | p. 218 |
| Mercaptopurine | p. 220 |
| Methotrexate | p. 222 |
| Methyl-CCNU | p. 226 |
| Mitomycin | p. 229 |
| Mitotane | p. 232 |
| Mitoxantrone | p. 233 |
| Nilutamide | p. 236 |
| Oxaliplatin | p. 238 |
| Paclitaxel | p. 242 |
| Pamidronate disodium | p. 250 |
| Pegasparaginase | p. 252 |
| Pentostatin | p. 255 |
| Plicamycin | p. 259 |
| Polifeprosan 20 with carmustine (BCNU) implant | p. 262 |
| Procarbazine hydrochloride | p. 265 |
| Progestational agents: medroxyprogesterone acetate, megestrol acetate | p. 268 |
| Raloxifene hydrochloride | p. 270 |
| Raltitrexed | p. 273 |
| Rebeccamycin analogue | p. 276 |
| Rubitecan | p. 278 |
| Streptozocin | p. 280 |
| Tamoxifen citrate | p. 283 |
| Temozolamide | p. 286 |
| Teniposide | p. 289 |
| Thioguanine | p. 292 |
| Thiotepa | p. 294 |
| Topotecan hydrochloride for injection | p. 296 |
| Toremifene citrate | p. 299 |
| Trimetrexate | p. 301 |
| UFT | p. 304 |
| UFT plus leucovorin | p. 305 |
| Valrubicin | p. 307 |
| Vinblastine | p. 310 |
| Vincristine | p. 313 |
| Vindesine | p. 315 |
| Vinorelbine tartrate | p. 318 |
| Biologic Response Modifier Therapy | p. 322 |
| Darbepoetin alfa | p. 326 |
| Epoetin alfa | p. 330 |
| Filgrastim | p. 332 |
| Interferon alfa ([alpha]) | p. 334 |
| Interferon alfa-2b | p. 338 |
| Interferon gamma | p. 342 |
| Interleukin-2 | p. 345 |
| Interleukin-3 | p. 351 |
| Interleukin-6 | p. 352 |
| Interleukin-12 | p. 354 |
| Levamisole hydrochloride | p. 356 |
| Megakaryocyte growth and development factor | p. 359 |
| Novel erythropoiesis stimulating protein | p. 360 |
| Oprelvekin | p. 361 |
| Pegfilgrastim | p. 364 |
| PIXY-321 | p. 368 |
| Sargramostim | p. 369 |
| Tumor necrosis factor | p. 371 |
| Antineoplastic Treatment Agonists: Radiosensitizers, Chemosensitizers, and Chemical Adjuncts | p. 375 |
| Chromic phosphate P32 suspension | p. 377 |
| Etanidazole | p. 379 |
| Fluosol DA (20%) | p. 381 |
| Leucovorin calcium | p. 382 |
| Porfirmer | p. 384 |
| Tirapazamine | p. 386 |
| Cytoprotective Agents | p. 389 |
| Allopurinol sodium | p. 393 |
| Amifostine for injection | p. 396 |
| Dexrazoxane for injection | p. 400 |
| Glutamine | p. 401 |
| Mesna | p. 403 |
| Molecularly Targeted Therapies | p. 405 |
| Alemtuzumab | p. 432 |
| Alitretinoin gel 0.1% | p. 435 |
| Arasentan | p. 437 |
| Bevacizumab | p. 438 |
| Bexarotene | p. 442 |
| Bortezomib | p. 448 |
| Cetuximab | p. 452 |
| Denileukin diftitox | p. 456 |
| Erlotinib | p. 461 |
| Gefitinib | p. 464 |
| Gemtuzumab ozogamicin for injection | p. 468 |
| [superscript 90]Y ibritumomab tiuxetan | p. 472 |
| Imatinib mesylate | p. 474 |
| Neovastat | p. 479 |
| Rituximab | p. 480 |
| Thalidomide | p. 484 |
| Tositumomab, I[superscript 131] tositumomab | p. 487 |
| Trastuzumab | p. 492 |
| Tretinoin | p. 495 |
| Liposomal tretinoin | p. 499 |
| Symptom Management | p. 505 |
| Pain | p. 506 |
| Non-opioid Analgesics | |
| Acetaminophen | p. 514 |
| Aspirin, acetylsalicylic acid | p. 516 |
| Celecoxib | p. 518 |
| Choline magnesium trisalicylate | p. 522 |
| Clonidine hydrochloride | p. 524 |
| Gabapentin | p. 526 |
| Ibuprofen | p. 530 |
| Indomethacin | p. 533 |
| Ketorolac tromethamine | p. 536 |
| Rofecoxib | p. 540 |
| Salsalate | p. 544 |
| Opioid Analgesics | |
| Codeine | p. 546 |
| Fentanyl citrate | p. 550 |
| Fentanyl transdermal system | p. 553 |
| Hydromorphone | p. 558 |
| Levorphanol tartrate opioid | p. 562 |
| Meperidine hydrochloride | p. 566 |
| Methadone | p. 570 |
| Morphine | p. 574 |
| Morphine-dextromethorphan | p. 579 |
| Oxycodone | p. 582 |
| Adjuvants Agents | |
| Modafinil | p. 586 |
| Nausea and Vomiting | p. 590 |
| Aprepitant | p. 597 |
| Dexamethasone | p. 599 |
| Diphenhydramine hydrochloride | p. 601 |
| Dolasetron mesylate | p. 603 |
| Dronabinol | p. 606 |
| Droperidol | p. 607 |
| Granisetron hydrochloride | p. 609 |
| Haloperidol | p. 611 |
| Metoclopramide hydrochloride | p. 612 |
| Ondansetron hydrochloride | p. 614 |
| Perphenazine | p. 616 |
| Prochlorperazine | p. 617 |
| Promethazine hydrochloride | p. 619 |
| Scopolamine | p. 621 |
| Thiethylperazine | p. 622 |
| Anorexia and Cachexia | p. 624 |
| Dronabinol | p. 626 |
| Megestrol acetate | p. 628 |
| Thalidomide | p. 629 |
| Anxiety and Depression | p. 633 |
| Alprazolam | p. 637 |
| Amitriptyline hydrochloride | p. 640 |
| Bupropion hydrochloride | p. 643 |
| Buspirone hydrochloride | p. 646 |
| Citalopram hydrobromide | p. 647 |
| Clonazepam | p. 651 |
| Desipramine hydrochloride | p. 654 |
| Diazepam | p. 657 |
| Doxepin hydrochloride | p. 660 |
| Fluoxetine hydrochloride | p. 663 |
| Imipramine pamoate | p. 667 |
| Lorazepam | p. 670 |
| Mirtazapine | p. 673 |
| Nefazodone HCl | p. 676 |
| Nortriptyline hydrochloride | p. 679 |
| Oxazepam | p. 682 |
| Paroxetine hydrochloride | p. 685 |
| Sertraline hydrochloride | p. 687 |
| Trazodone hydrochloride | p. 690 |
| Venlafaxine hydrochloride | p. 693 |
| Zolpidem tartrate | p. 697 |
| Complications | p. 701 |
| Hypercalcemia | p. 702 |
| Calcitonin-salmon | p. 705 |
| Etidronate disodium | p. 707 |
| Furosemide | p. 709 |
| Gallium nitrate | p. 711 |
| Pamidronate disodium | p. 713 |
| Zoledronic acid | p. 715 |
| Infection | p. 719 |
| Antibiotics | |
| Amikacin sulfate | p. 728 |
| Amoxicillin | p. 731 |
| Ampicillin | p. 735 |
| Azithromycin | p. 738 |
| Aztreonam | p. 740 |
| Carbenicillin indanyl sodium | p. 744 |
| Cefaclor | p. 747 |
| Cefadroxil | p. 750 |
| Cefamandole nafate | p. 751 |
| Cefazolin sodium | p. 755 |
| Cefdinir | p. 759 |
| Cefditoren pivoxil | p. 762 |
| Cefepime | p. 764 |
| Cefixime | p. 767 |
| Cefoperazone sodium | p. 770 |
| Cefotaxime sodium | p. 773 |
| Cefotetan | p. 776 |
| Cefoxitin sodium | p. 778 |
| Cefpodoxime proxetil | p. 782 |
| Cefprozil | p. 784 |
| Ceftazidime | p. 786 |
| Ceftibuten | p. 790 |
| Ceftriaxone sodium | p. 791 |
| Cefuroxime | p. 795 |
| Cephalexin | p. 797 |
| Cephapirin | p. 799 |
| Cephradine | p. 801 |
| Ciprofloxacin | p. 805 |
| Clarithromycin | p. 808 |
| Clindamycin phosphate | p. 811 |
| Co-trimoxazole; trimethoprim and sulfamethoxazole | p. 814 |
| Dicloxacillin sodium | p. 818 |
| Doxycycline hyclate | p. 821 |
| Ertapenem | p. 824 |
| Erythromycin | p. 826 |
| Gatifloxacin | p. 830 |
| Gentamicin sulfate | p. 833 |
| Impienem/cilastatin sodium | p. 836 |
| Kanamycin sulfate | p. 840 |
| Levofloxacin | p. 843 |
| Linezolid | p. 847 |
| Metronidazole hydrochloride | p. 849 |
| Mezlocillin sodium | p. 852 |
| Minocycline hydrochloride | p. 856 |
| Moxifloxacin | p. 859 |
| Nafcillin sodium | p. 862 |
| Oxacillin sodium | p. 865 |
| Penicillin G | p. 869 |
| Piperacillin sodium | p. 872 |
| Quinupristin and dalfopristin | p. 876 |
| Streptomycin sulfate | p. 879 |
| Ticarcillin disodium | p. 883 |
| Tobramycin sulfate | p. 887 |
| Vancomycin hydrochloride | p. 890 |
| Antifungals | |
| Amphotericin B, amphotericin B lipid complex | p. 894 |
| Caspofungin | p. 898 |
| Fluconazole | p. 900 |
| Flucytosine | p. 903 |
| Itraconazole | p. 905 |
| Ketoconazole | p. 908 |
| Miconazole nitrate | p. 910 |
| Nystatin | p. 913 |
| Voriconazole | p. 915 |
| Antivirals | |
| Acyclovir | p. 916 |
| Cidofovir | p. 919 |
| Famiclovir | p. 923 |
| Foscarnet sodium | p. 924 |
| Ganciclovir | p. 928 |
| Valacyclovir hydrochloride | p. 931 |
| Constipation | p. 933 |
| Bisacodyl | p. 934 |
| Docusate calcium, docusate potassium, docusate sodium | p. 936 |
| Glycerin suppository | p. 937 |
| Lactulose | p. 938 |
| Magnesium citrate | p. 939 |
| Methylcellulose | p. 941 |
| Mineral oil | p. 942 |
| Polyethylene glycol 3350, NF powder | p. 943 |
| Senna | p. 945 |
| Sorbitol | p. 946 |
| Diarrhea | p. 948 |
| Deodorized tincture of opium | p. 950 |
| Diphenoxylate hydrochloride and atropine | p. 951 |
| Kaolin/pectin | p. 953 |
| Loperamide hydrochloride | p. 954 |
| Octreotide acetate | p. 955 |
| Controlling Occupational Exposure to Hazardous Drugs | p. 959 |
| National Cancer Institute Common Toxicity Criteria | p. 989 |
| Cancer Chemotherapeutic Regimens (Adult) | p. 1064 |
| Index | p. 1115 |
| Table of Contents provided by Rittenhouse. All Rights Reserved. |
What is included with this book?
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.
Please wait while the item is added to your bag...
